[1-([1]Benzofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl][4-(4-chlorophenyl)piperazin-1-yl]methanone结构式
|
常用名 | [1-([1]Benzofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl][4-(4-chlorophenyl)piperazin-1-yl]methanone | 英文名 | [1-([1]Benzofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl][4-(4-chlorophenyl)piperazin-1-yl]methanone |
|---|---|---|---|---|
| CAS号 | 1112429-10-3 | 分子量 | 476.0 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C26H26ClN5O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | [1-([1]Benzofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl][4-(4-chlorophenyl)piperazin-1-yl]methanone |
|---|
| 分子式 | C26H26ClN5O2 |
|---|---|
| 分子量 | 476.0 |
| InChIKey | KSTBKOJPGLXWEP-UHFFFAOYSA-N |
| SMILES | C1CN(CCC1C(=O)N2CCN(CC2)C3=CC=C(C=C3)Cl)C4=NC=NC5=C4OC6=CC=CC=C65 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|